Is sirolimus a treatment option for patients with systemic lupus erythematosus?

Affiliations

¹ Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey. nihalesatoglu@gmail.com.
² Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey.

Free article

Comment

Sinem Nihal Esatoglu et al. Clin Exp Rheumatol. 2019 Nov-Dec.

Free article

. 2019 Nov-Dec;37 Suppl 122(6):13.

Epub 2019 Jul 12.

¹ Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey. nihalesatoglu@gmail.com.
² Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey.

No abstract available

Comment on

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.
Lai ZW, Kelly R, Winans T, Marchena I, Shadakshari A, Yu J, Dawood M, Garcia R, Tily H, Francis L, Faraone SV, Phillips PE, Perl A. Lai ZW, et al. Lancet. 2018 Mar 24;391(10126):1186-1196. doi: 10.1016/S0140-6736(18)30485-9. Epub 2018 Mar 15. Lancet. 2018. PMID: 29551338 Free PMC article. Clinical Trial.